Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lugt, Pablo van der
22  Ergebnisse:
Personensuche X
?
1

Engineered Bamboo Products – A Sustainable Choice?:

, In: Cultivated Building Materials,
Lugt, Pablo van der - p. 86-95 , 2017
Link: https://doi.org/10.1515/..
 
?
2

Carbon sequestration in LCA, a proposal for a new approach ..:

Vogtländer, Joost G. ; van der Velden, Natascha M. ; van der Lugt, Pablo
The International Journal of Life Cycle Assessment.  19 (2013)  1 - p. 13-23 , 2013
Link: https://doi.org/10.1007/..
 
?
3

The sustainability of bamboo products for local and Western..:

Vogtländer, Joost ; van der Lugt, Pablo ; Brezet, Han
Journal of Cleaner Production.  18 (2010)  13 - p. 1260-1269 , 2010
Link: https://doi.org/10.1016/..
 
?
4

Dutch design meets Bamboo:

Lugt, Pablo van der , 2007
Exemplar:  TB Kunst: 744.1 BAM
 
?
5

Markets for bamboo products in the west ; Salidas comercial..:

Van der Lugt, Pablo ; Lobovikov, Maxim
https://revues.cirad.fr/index.php/BFT/article/view/20395/20154.  , 2008
Link: https://revues.cirad.fr/..
 
?
6

LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRA..:

Kline, Cassie ; Waanders, Angela J ; Ziegler, David S...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
7

Author Correction: The type II RAF inhibitor tovorafenib in..:

Kilburn, Lindsay B. ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R....
Nature Medicine.  30 (2024)  5 - p. 1500-1500 , 2024
Link: https://doi.org/10.1038/..
 
?
8

The type II RAF inhibitor tovorafenib in relapsed/refractor..:

Kilburn, Lindsay B. ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R....
Nature Medicine.  30 (2023)  1 - p. 207-217 , 2023
Link: https://doi.org/10.1038/..
 
?
9

CTNI-37. CLINICAL ACTIVITY OF RAF INHIBITOR TOVORAFENIB ACC..:

Khuong-Quang, Dong-Anh ; Nysom, Karsten ; Landi, Daniel...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v82-v83 , 2023
Link: https://doi.org/10.1093/..
 
?
10

LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB ..:

Kilburn, Lindsay ; Khuong-Quang, Dong-Anh ; Nysom, Karsten...
Neuro-Oncology.  25 (2023)  Supplement_1 - p. i57-i57 , 2023
Link: https://doi.org/10.1093/..
 
?
11

CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHI..:

Kilburn, Lindsay ; Landi, Daniel ; Leary, Sarah...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii89-vii89 , 2022
Link: https://doi.org/10.1093/..
 
?
12

The type II RAF inhibitor tovorafenib in relapsed/refractor..:

Kilburn, Lindsay B ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803270/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB ..:

Kilburn, Lindsay ; Khuong-Quang, Dong-Anh ; Nysom, Karsten...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260080/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Association of Rare APOE Missense Variants V236E and R251G ..:

Le Guen, Yann ; Belloy, Michael E ; Grenier-Boley, Benjamin...
http://hdl.handle.net/10668/22161.  , 2022
Link: http://hdl.handle.net/10..
 
?
15

Association of Rare APOE Missense Variants V236E and R251G ..:

Le Guen, Yann ; Belloy, Michael E ; Grenier-Boley, Benjamin...
info:eu-repo/semantics/altIdentifier/pmid/35639372.  , 2022
Link: https://hdl.handle.net/2..
 
1-15